PT Kimia Farma Tbk (ISX:KAEF) Short-Term Debt: Rp2,273,702 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ISX:KAEF PT Kimia Farma Tbk ISX:KAEF
56 GF Score
Price Rp452.00
GF Value Rp580.85
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is PT Kimia Farma Tbk Short-Term Debt?

PT Kimia Farma Tbk ISX:KAEF +0.44% 56 Short-Term Debt is Rp2,273,702 Mil as of Mar. 2026. GuruFocus rates ISX:KAEF with a GF Score™ of 56/100 and a GF Value™ of Rp580.85 (Modestly Undervalued). The stock has 4 warning signs investors should review.

PT Kimia Farma Tbk's Short-Term Debt for the quarter that ended in Mar. 2026 was Rp2,273,702 Mil.

PT Kimia Farma Tbk's quarterly Short-Term Debt increased from Sep. 2025 (Rp3,257,661 Mil) to Dec. 2025 (Rp3,505,577 Mil) but then declined from Dec. 2025 (Rp3,505,577 Mil) to Mar. 2026 (Rp2,273,702 Mil).

PT Kimia Farma Tbk's annual Short-Term Debt declined from Dec. 2023 (Rp6,928,799 Mil) to Dec. 2024 (Rp4,497,938 Mil) and declined from Dec. 2024 (Rp4,497,938 Mil) to Dec. 2025 (Rp3,505,577 Mil).

PT Kimia Farma Tbk Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

PT Kimia Farma Tbk Short-Term Debt Related Terms

PT Kimia Farma Tbk Short-Term Debt Historical Data

* Premium members only.

The historical data trend for PT Kimia Farma Tbk's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PT Kimia Farma Tbk Short-Term Debt Chart

PT Kimia Farma Tbk Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Short-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4,741,902.13 6,378,398.95 6,928,798.69 4,497,937.68 3,505,576.67

PT Kimia Farma Tbk Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Short-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3,243,068.48 3,253,444.93 3,257,660.74 3,505,576.67 2,273,702.46
ISX:KAEF
56GF Score
PT Kimia Farma Tbk ISX:KAEF
Short-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Short-Term Debt →
What does a Short-Term Debt of Rp2,273,702 Mil mean?
PT Kimia Farma Tbk (ISX:KAEF) has a Short-Term Debt of Rp2,273,702 Mil as of Mar. 2026.
Is PT Kimia Farma Tbk's Short-Term Debt too high?
PT Kimia Farma Tbk's current Short-Term Debt is Rp2,273,702 Mil. Overall, PT Kimia Farma Tbk has a GF Score™ of 56/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does PT Kimia Farma Tbk's Short-Term Debt compare to MCK and COR?
PT Kimia Farma Tbk's Short-Term Debt of Rp2,273,702 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Short-Term Debt for a Medical Distribution company?
A good Short-Term Debt depends on the Medical Distribution industry context. However, Short-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Short-Term Debt mean?
A high Short-Term Debt can signal that a stock is expensive relative to its fundamentals. PT Kimia Farma Tbk's current Short-Term Debt is Rp2,273,702 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Kimia Farma Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Kimia Farma Tbk (ISX:KAEF) is currently considered Modestly Undervalued. The stock's GF Value™ is Rp580.85, compared to a current price of Rp452.00 — trading 22.2% below its estimated fair value. The current Short-Term Debt is Rp2,273,702 Mil. PT Kimia Farma Tbk's overall GF Score™ is 56/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Short-Term Debt calculated?
Short-Term Debt is calculated from a company's financial statements. For PT Kimia Farma Tbk (ISX:KAEF), the current Short-Term Debt is Rp2,273,702 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is PT Kimia Farma Tbk (ISX:KAEF) Overvalued in 2026?

Based on GuruFocus' analysis, PT Kimia Farma Tbk stock appears to be undervalued. The current stock price of Rp452.00 is trading 22.2% below its estimated GF Value™ of Rp580.85. GuruFocus considers PT Kimia Farma Tbk to be Modestly Undervalued.

Key valuation signals for ISX:KAEF:

  • Short-Term Debt: Rp2,273,702 Mil
  • GF Value™: Rp580.85 vs. price of Rp452.00 (22.2% below fair value)
  • GF Score™: 56/100 with 4 warning signs

No single metric tells the full story. See the ISX:KAEF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

PT Kimia Farma Tbk Business Description

Address Jalan Veteran No. 9 Gambir, Jakarta Pusat, Jakarta, IDN, 10110
PT Kimia Farma Tbk is an Indonesia-based company engaged in the production and distribution of healthcare products. It operates through the following segments: Manufacture, Distribution, Retail, and Others. The company provides its products in categories including OTC & Herb, Ethical, Cosmetic, Generic, and others. Some of its product offerings include Alergine, Kimoxil, Loprezol, Enkasari, and Batugin among others. It generates maximum revenue from the Retail segment.
56GF Score

Get the complete analysis for ISX:KAEF

Short-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

Rp452.00
Price
Rp580.85
GF Value